|
Volumn , Issue WINTER, 2004, Pages 92-97
|
Reducing risk in biopharmaceutical production by controlling glycosylation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
GLYCAN;
IMMUNOGLOBULIN FC FRAGMENT;
MONOCLONAL ANTIBODY;
MONOSACCHARIDE;
OLIGOSACCHARIDE;
RECOMBINANT ERYTHROPOIETIN;
ANALYTIC METHOD;
ANALYTICAL PARAMETERS;
BIOTECHNOLOGY;
CARBOHYDRATE ANALYSIS;
CELL CULTURE;
CHEMICAL COMPOSITION;
CONTROL SYSTEM;
DRUG HALF LIFE;
DRUG MANUFACTURE;
DRUG SAFETY;
DRUG STRUCTURE;
FOOD AND DRUG ADMINISTRATION;
GLYCOSYLATION;
NOTE;
QUALITATIVE ANALYSIS;
QUALITY CONTROL;
QUANTITATIVE ANALYSIS;
RISK ASSESSMENT;
RISK REDUCTION;
STRUCTURE ACTIVITY RELATION;
VALIDATION PROCESS;
|
EID: 13244299336
PISSN: 1364369X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|